Overview

A Study of AG-80308 in Dry Eye Patients

Status:
Not yet recruiting
Trial end date:
2022-10-09
Target enrollment:
Participant gender:
Summary
This is a multicenter, double-masked, randomized, parallel-group study with topical AG-80308 eye drops in dry eye patients.
Phase:
Phase 1
Details
Lead Sponsor:
Allgenesis Biotherapeutics Inc.
Collaborator:
ORA, Inc.